Amsterdam UMC spin-off PacingCure received EIC Transition funding
September 20, 2022Amsterdam UMC spin-off PacingCure received a prestigious EIC Transition grant of 2.5 million euros.
PacingCure develops platform gene transfer technologies for the heart and uses these technologies to engineer novel treatments for cardiac arrhythmias in patients with high unmet medical needs. The selected indications have attractive translational aspects for developing advanced therapy medicinal products (ATMP) for patients that need them the most.
The three founders, Geert Boink, Osne Kirzner, Hanno Tan, and their co-applicant Prof. Vincent Christoffels (Amsterdam UMC), were awarded the prestigious Transition grant from the European Innovation Council (EIC) for their achievements and planned activities to develop their core technologies towards clinical implementation. The current EIC project will fund a comprehensive package of final stage pre-clinical development, align with regulatory authorities and develop an investor-ready business proposition.
About the founders
Geert Boink is a cardiologist, leading a translational research group that is embedded in the Departments of Cardiology and Medical Biology. Dr. Boink also serves as the CEO of PacingCure. Hanno Tan is a cardiologist, and Principal Investigator at the Department of Clinical and Experimental Cardiology who leads various European consortia that study the causes and develop treatments for sudden cardiac arrest. Dr. Tan serves as the CMO of PacingCure. Osne Kirzner is an anesthesiologist with experience in finance & law. This combined expertise allows him to bridge the gap between the target clinical indications and business needs, thereby facilitating valorization objectives. Osne serves as the CFO of PacingCure.
Previously, PacingCure received funding from, among others, Health Holland, the Innovatiefonds Noord Holland, the Nederlandse Wetenschappelijke Organisatie (NWO), and the European Commission.
Support by IXA
IXA has supported Pacing Cure over the years, among other things by participating in PacingCure’s advisory group and thus preparing their team for the oral defense with this grant. Business developer Marc Roelofs also played an important role in developing their business case during the Venture Challenge in 2020 (and beyond), which they also won.
More news
Funding from KWF for palliative cancer patients in meaning-making at home
The diagnosis of incurable cancer profoundly disrupts patients’ lives, often causing existential crises and a sense of lost purpose. The KWF-funded project “In Search of Stories” (ISOS) aimed to support these patients by partnering them with spiritual counsellors and professional artists. This co-creation process proved highly beneficial. New funding from KWF Dutch Cancer Society supports […]
News
Max Nieuwdorp’s innovative research on gut microbes: a path to combat fatty liver disease
Internist Max Nieuwdorp, of Amsterdam UMC, discovered a few years ago that the microorganisms in the intestines of many overweight people produce alcohol to an increased extent. Breaking down excessive alcohol leads to fatty liver disease, which in turn poses a risk of serious conditions such as diabetes and cardiovascular disease. Nieuwdorp has now received an ERC Advanced Grant of 2.5 million euros for a major study into the underlying causes of this excessive alcohol production.
News
Impact in education and beyond: VU researcher Laura Rupp secures Comenius Leadership Fellow grant
Laura Rupp has been awarded the Comenius Leadership Fellow grant for a three-year period. This grant of 500,000 Euros, will fund a project titled “Global English and International Dutch on the VU Campus”. Over the years, Rupp has successfully reached more than 100,000 people online worldwide, teaching how to understand diverse English accents and speak […]
News